GNE-490

CAS No. 1033739-92-2

GNE-490( GNE490 )

Catalog No. M10164 CAS No. 1033739-92-2

GNE-490 is a potent, selective, orally available class I PI3K inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 312 Get Quote
10MG 507 Get Quote
25MG 802 Get Quote
50MG 1107 Get Quote
100MG 1503 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GNE-490
  • Note
    Research use only, not for human use.
  • Brief Description
    GNE-490 is a potent, selective, orally available class I PI3K inhibitor.
  • Description
    GNE-490 is a potent, selective, orally available class I PI3K inhibitor with IC50 of 3.5/25/5.2/15 nM for PI3Kα/PI3Kβ/PI3Kγ/PI3Kδ; shows >200-fold selectivity over mTOR (IC50=740 nM); has good PK profiles, and are efficacious in xenograft models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GNE490
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1033739-92-2
  • Formula Weight
    386.474
  • Molecular Formula
    C18H22N6O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (258.75 mM)
  • SMILES
    CC1=NC(=NC=C1C2=NC3=C(C(=N2)N4CCOCC4)SC(=C3)C(C)(C)O)N
  • Chemical Name
    2-(2-Amino-4-methyl-5-pyrimidinyl)-α,α-dimethyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidine-6-methanol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sutherlin DP, et al. J Med Chem. 2010 Feb 11;53(3):1086-97. 2. Sampath D, et al. Neoplasia. 2013 Jul;15(7):694-711.
molnova catalog
related products
  • Myricetin

    Myricetin is produced from the parent compound taxifolin through the (+)-dihydromyricetin intermediate and can be further processed to form laricitrin and then syringetin, both members of the flavonol class of flavonoids.

  • Tenalisib (RP6530)

    Tenalisib shows selectivity over PI3K α (>300-fold) and β (>100-fold) isoforms. Tenalisib exhibits modest proliferation inhibition in both HEL-RS and HEL-RR cells.

  • IHMT-PI3Kδ-372 S-iso...

    IHMT-PI3Kδ-372 S-isomer is a potent and selective PI3Kδ inhibitor with an IC50 of 14 nM. IHMT-PI3Kδ-372 S-isomer shows high selectivity over other class I PI3Ks (56~83 fold) and other protein kinases.